Event Registration for Clinicians | Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment — April 3, 2017, Washington, DC


Submissions for this form are closed.

This activity is intended for medical oncologists, hematologists, surgeons, radiation oncologists, oncology nurses and other healthcare professionals involved in basic, translational and clinical cancer research or treatment.

You are now registering as a practicing physician, fellow or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, click here to register as a nonclinician.

Meeting Information
Meeting:

Molecular Tumor Board: Integrating Biomarker Analyses into Clinical Decision-Making Regarding the Use of Immune Checkpoint Inhibitors in Cancer Treatment

Date:

Monday, April 3, 2017

Time (Eastern Time):

6:30 PM – 7:00 PM
Registration and Buffet Dinner 7:00 PM – 9:00 PM
Educational Program

Location:

Grand Hyatt Washington
1000 H St NW
Washington, DC 20001
Hotel Phone: (202) 582-1234

Meeting Room:

Independence Ballroom A (Level 5B)

Faculty:

Johanna C Bendell, MDCharles G Drake, MD, PhDRoy S Herbst, MD, PhDDavid F McDermott, MDCraig Moskowitz, MD

Moderator:

Neil Love, MD